Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.34 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | CYP51A1 | Q16850 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13303907 | 0.88 | SIGMAR1 (0.37) | HSD17B1HSD17B2MAPTMAPK1TDP1 | |
| SCHEMBL13303904 | 0.85 | — | — | |
| SCHEMBL13792987 | 0.84 | TDP1 (0.40) | HSD17B1HSD17B2MAPTNR1I2LMNA | |
| SCHEMBL13615778 | 0.83 | HSD17B1 (0.35) | HSD17B1HSD17B2MAPTCYP1A2CYP3A4 | |
| SCHEMBL22151752 | 0.82 | CYP11B1 (0.39) | HSD17B1HSD17B2GPR84MAPTLMNA | |
| SCHEMBL13303900 | 0.82 | SIGMAR1 (0.40) | MAPTNR1I2LMNACYP1A2CYP3A4 | |
| SCHEMBL25778845 | 0.81 | HSD17B1 (0.38) | HSD17B1HSD17B2MAPTNR1I2LMNA | |
| SCHEMBL25778897 | 0.81 | ESR1 (0.38) | HSD17B1HSD17B2GPR84MAPTNR1I2 | |
| SCHEMBL9963836 | 0.81 | HSD17B1 (0.41) | HSD17B1HSD17B2MAPTSIGMAR1MEN1 | |
| SCHEMBL9963849 | 0.81 | HSD17B1 (0.41) | HSD17B1HSD17B2MAPTSIGMAR1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090295281-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-12-03 | — | — | US | disclosed |
| US-20090295281-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-12-03 | — | — | US | disclosed |
| US-20090261714-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-10-22 | — | — | US | disclosed |
| US-20090261714-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-10-22 | — | — | US | disclosed |
| EP-2098532-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2009-09-09 | — | — | EP | disclosed |
| EP-2090637-A1 | Organic electroluminescent compounds and light emitting diode using the same | Gracel Display Inc. (KR) | 2009-08-19 | — | — | EP | disclosed |
| EP-2085450-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2009-08-05 | — | — | EP | disclosed |
| US-20090189519-A1 | Organic electroluminescent compounds and light emitting diode using the same | GRACEL DISPLAY INC. (KR) | 2009-07-30 | — | — | US | disclosed |
| US-20090189519-A1 | Organic electroluminescent compounds and light emitting diode using the same | GRACEL DISPLAY INC. (KR) | 2009-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090189519-A1 | Organic electroluminescent compounds and light emitting diode using the same | OCIAD1, AOX1, OCIAD2 | PTGS2 1618/4885HSD17B1 504/4885HSD17B2 897/4885 |
| US-20090261714-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | AOX1, ODC1, LEF1 | PTGS2 1889/4885HSD17B1 1457/4885HSD17B2 1877/4885 |
| US-20090295281-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | AOX1, LEF1, ODC1 | PTGS2 1682/4885HSD17B1 1337/4885HSD17B2 1798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.